Toxicological effects of a cationic clay, montmorillonite in vitro and in vivo

Molecular and Cellular Toxicology

Volumn 8, Issue 1, 2012, Pages 95-101

  Baek, Miri ^a   Lee, Jeong A ^a   Choi, Soo Jin ^a  

^a Seoul Women University   (South Korea)

Author keywords

Acute oral toxicity; Cationic clays; Cytotoxicity; Montmorillonite (MMT); Pharmacokinetics

Indexed keywords

MONTMORILLONITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CATION EXCHANGE; CELL PROLIFERATION; CLAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LD 50; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; STATIC ELECTRICITY; TOXICOLOGY;

EID: 84859530382     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-012-0012-x     Document Type: Article

References (23)

1. S. L. Swartzen-Allen E. Matijevic 1974 Surface and colloid chemistry of clays Chem Revs 74 74385 74400 10.1021/cr60289a004
2. F. Tomas, et al. 1999 Layer charge and eletrophoretic mobility of smectites Colloids Surf 159 351 358 10.1016/S0927-7757(99)00291-5 (Pubitemid 29535446)
3. W. F. Lee Y. T. Fu 2003 Effect of montmorillonite on the swelling behavior and drug-release behavior of nanocomposite hydrogels Appl Polym Scl 89 3652 3660 10.1002/app.12624 1:CAS:528:DC%2BD3sXmsVajs7s%3D (Pubitemid 36984434)
4. H. Komine 2004 Simplified evaluation for swelling characteristics of bentonites Eng Geol 71 256 279 10.1016/S0013-7952(03)00140-6 (Pubitemid 38127090)
5. C. C. Aguzzi P. Cerezo C. Viseras C. Caramella 2007 Use of clays as drug delivery systems: Possibilities and limitations Appl Clay Sci 36 22 36 10.1016/j.clay.2006.06.015 1:CAS:528:DC%2BD2sXjtFGgs7o%3D (Pubitemid 46404593)
6. A. J. Ramos E. Hernández 1996 In vitro aflatoxin adsorption by means of a montmorillonite silicate. A study of adsorption isotherms Anim Feed Sci Technol 62 263 269 10.1016/S0377-8401(96)00968-6 1:CAS:528: DyaK28XntlSqt7c%3D (Pubitemid 126366332)
7. J. P. Zheng L. Luan H. Y. Wang L. F. Xi K. D. Yao 2007 Study on ibuprofen/montmorillonite intercalation composites as drug release system Appl Clay Sci 36 297 301 10.1016/j.clay.2007.01.012 1:CAS:528:DC%2BD2sXkslentrg%3D (Pubitemid 46621736)
8. A. A. Fudala I. Pálinkó I. Kiricsi 1999 Preparation and characterization of hybrid organic-inorganic composite materials using the amphoteric property of amino acids: amino acid intercalated layered double hydroxide and montmorillonite Inorg Chem 38 4653 4658 10.1021/ic981176t 1:CAS:528:DyaK1MXlvFKit7g%3D
9. T. Kollár I. Pálinkó Z. Kónya I. Kiricsi 2003 Intercalating amino acid guests into montmorillonite host J Mol Struct 651-653 335 340 10.1016/S0022-2860(03)00109-1 (Pubitemid 36722977)
10. F. H. Jin, et al. 2002 A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier Biomaterials 23 1981 1987 10.1016/S0142-9612(01)00325-8 (Pubitemid 34251072)
11. J. K. Park, et al. 2008 Controlled release of donepezil intercalated in smectite clays Int J Pharm 359 198 204 18502063 10.1016/j.ijpharm.2008.04.012 1:CAS:528:DC%2BD1cXmvVemsr8%3D
12. H. Jung H. M. Kim Y. B. Choy S. J. Hwang J. H. Choy 2008 Itraconazole-Laponite: Kinetics and mechanism of drug release Appl Clay Sci 40 99 107 10.1016/j.clay.2007.09.002 1:CAS:528:DC%2BD1cXmsF2jsLk%3D (Pubitemid 351737246)
13. H. Jung H. M. Kim Y. B. Choy S. J. Hwang J. H. Choy 2008 Laponite-based nanohybrid for enhanced solubility and controlled release of itraconzaole Int J Pharm 349 283 290 17888597 10.1016/j.ijpharm.2007.08.008 1:CAS:528: DC%2BD1cXhtFCgsQ%3D%3D (Pubitemid 350299711)
14. J. Yu M. Baek H. E. Chung S. J. Choi 2010 Physicochemical properties affecting the potential in vitro cytotoxicity of inorganic layered nanoparticles Toxicol Environ Health Sci 2 149 152 10.1007/BF03216498
15. E. J. Murphy E. Roberts L. A. Horrocks 1993 Aluminum silicate toxicity in cell cultures Neuroscience 55 597 605 8397348 10.1016/0306-4522(93)90527-M 1:CAS:528:DyaK3sXlslGmt7Y%3D (Pubitemid 23211370)
16. Y. H. Lee, et al. 2005 Toxicity assessment of montmorillonite as a drug carrier for pharmaceutical applications: yeast and rats model Biomed Eng Appl Basis Comm 17 12 18 10.4015/S1016237205000032
17. E. Herzog, et al. 2007 A new approach to the toxicity testing of carbon-based nanomaterials-The clonogenic assay Toxicol Lett 174 49 60 17920791 10.1016/j.toxlet.2007.08.009 1:CAS:528:DC%2BD2sXht1anurbJ (Pubitemid 47599861)
18. M. Baek, et al. 2011 Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge J Phys Conf Ser 304 1 7 10.1088/1742-6596/304/1/012044
19. G. kallifatidis, et al. 2011 Sulforaphane increases drug-modiated cytotoxicity toward cancer stem-like cells of pancreas and prostate Mol Ther 19 188 195 20940707 10.1038/mt.2010.216 1:CAS:528:DC%2BC3cXht1OmtbfO
20. R. I. Lliescu E. Andronescu G. Voicu A. Ficai C. I. Covaliu 2011 Hybrid materials based on montmorillonite and citostatic drugs: Preparation and charctrization Appl Clay Sci 52 62 68 10.1016/j.clay.2011.01.031
21. Y. Dong S. S. Feng 2005 Poly (D, L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs Biomaterials 26 6068 6076 15894372 10.1016/j.biomaterials.2005.03.021 1:CAS:528:DC%2BD2MXlt1Wgtro%3D (Pubitemid 40805612)
22. J. D. Lambert S. Sang J. Hong C. S. Yang 2010 Anticancer and anti-inflammatory effects of cysteine metabolites of the green tea polyphenol, (-)-epigallocatechin-3-gallate J Agric Food Chem 58 10016 10019 20718469 10.1021/jf102311t 1:CAS:528:DC%2BC3cXhtVCns7jP
23. H. E. Chung I. S. Kim M. Baek J. Yu S. J. Choi 2011 Long-term cytotoxicity potential of anionic nanoclays in human cells Toxicol Environ Health Sci 3 129 133 10.1007/s13530-011-0088-z